Natalia Lynch

Weekly Stewards and Commissions Rulings: Nov 7-13

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from around the country. Among the key rulings from the last seven days, trainer Natalia Lynch has been handed down a combined four-year suspension by an arbitrator, and a combined $55,000 in fines and arbitration costs. Lynch had faced sanctions for two separate issues. One was for the possession of banned thyroid drug, Levothyroxine. The other was a positive test for another banned substance, Altrenogest—a synthetic progestin used in horses for the purpose of suppressing...

[ Read More ]
Trainer Lynch Plans Appeal After HIWU Arbitrator Imposes 4-Year Banned Substances Suspension

Natalia Lynch, a Belmont Park-based trainer who has been licensed since 2020, has been penalized with a four-year suspension and a $50,000 fine after a Nov. 9 Horseracing Integrity and Welfare Unit (HIWU) arbitration judgment found her to be in violation of two separate anti-doping rules, one for the presence of a banned substance (Altrenogest) in a horse, and another for possession of a different prohibited drug (Thyro-L). Lynch's attorney, John Mac Hayes, told TDN Monday that the trainer plans to appeal the arbitration result to a Federal Trade Commission...

[ Read More ]
Four Additional Trainers Handed Provisional Suspensions By HIWU

The Horseracing Integrity and Welfare Unit (HIWU) has updated its list of trainers that have been provisionally suspended after their horses have allegedly tested positive for banned substances, and the new names are Natalia Lynch, David Reid, Javier Morzan and Mary Pirone. Lynch, who is based in New York and had a winner Sunday at Saratoga, was sanctioned for allegedly having a horse test positive for Altrenogest. According a 2018 press release from the Racing Medication and Testing Consortium (RMTC), Altrenogest is a progesterone receptor agonist used to control estrus...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.